Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulphate in Acute Ischemic Stroke
NCT04412850Phase 1Unknown
- Sponsor
- Dow University of Health Sciences
- Start
- Dec 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in ischemic stroke comparing Control group (Magnesium Sulfate) with Placebo group (2 arms). Primary endpoint: NIH Stroke Scale at 7 days. Status: unknown.
02
Drugs
magnesium sulfate
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04412850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04412850.